Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: A randomized, placebo-controlled trial

BMC Musculoskeletal Disorders

Volumn 9, Issue , 2008, Pages

  Spector, Tim D ^a   Calomme, Mario R ^b   Anderson, Simon H ^a   Clement, Gail ^a   Bevan, Liisa ^a   Demeester, Nathalie ^b   Swaminathan, Rami ^a   Jugdaohsingh, Ravin ^a,c,d   Berghe, Dirk A Vanden ^b   Powell, Jonathan J ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CHOLINE; COLECALCIFEROL; COLLAGEN TYPE 1; PLACEBO; SILICIC ACID; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; COLLAGEN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL SUPPORT; OSSIFICATION; OSTEOPENIA; RANDOMIZED CONTROLLED TRIAL; DRUG COMBINATION; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; POSTMENOPAUSE; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCIUM; CHOLECALCIFEROL; CHOLINE; COLLAGEN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; SILICIC ACID; TREATMENT OUTCOME;

EID: 46149099349     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-9-85     Document Type: Article

References (55)

1. Clinical review 76: the nature of osteoporosis. R Marcus, J Clin Endocrinol Metab 1996 81 1 5 8550734 10.1210/jc.81.1.1
2. Genetics, calcium intake and osteoporosis. JA Eisman, Proc Nutr Soc 1998 57 187 193 9656320 10.1079/PNS19980031
3. What is osteoporosis? C Christodoulou C Cooper, Postgrad Med J 2003 79 133 138 12697910 10.1136/pmj.79.929.133
4. Nutritional influences on bone mass. DM Reid SA New, Proc Nutr Soc 1997 56 977 987 9483664 10.1079/PNS19970103
5. Risks and benefits of estrogen plus progestin healthy postmenopausal women: principal results from the women's health initiative investigators. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene Writing Group for the Women's Health Initiative Investigators, JAMA 2002 228 321 333
6. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progesterin replacement study. D Grady NK Wenger D Herrington S Khan C Furberg D Hunninghake E Vittinghoff S Hulley, Ann Intern Med 2000 132 9 689 96 10787361
7. Oral dialy ibandronate prevents bone loss in early postmenopausal women without osteoporosis. MR McClung RD Wasnich R Recker JA Cauley CH Chesnut KE Ensrud A Burdeska T Mills Oral Ibandronate Study Group, J Bone Miner Res 2004 19 11 18 14753731 10.1359/JBMR.0301202
8. Daily oral magnesium supplementation suppresses bone turnover in young adult males. HP Dimai S Porta G Wirnsberger M Lindschinger I Pamperl H Dobnig M Wilders-Truschnig KH Lau, J Clin Endocrinol Metab 1998 83 2742 2748 9709941 10.1210/jc.83.8.2742
9. Molecular mechanism of action of fluoride on bone cells. KH Lau DJ Baylink, J Bone Miner Res 1998 13 1660 1667 9797473 10.1359/jbmr.1998.13.11.1660
10. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. CY Pak K Sakhaee B Adams-Huet V Piziak RD Peterson JR Poindexter, Ann Intern Med 1995 123 6 401 408 7639438
11. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. L Strause P Saltman KT Smith M Bracker MB Andon, J Nutr 1994 124 7 1060 1064 8027856
12. Zinc, biochemical markers of nutrition, and type I osteoporosis. P Relea M Revilla E Ripoll I Arribas LF Villa H Rico, Age Ageing 1995 24 303 307 7484487 10.1093/ageing/24.4.303
13. Nutrition and bone: is there more to it than just calcium and vitamin D. DM Reid HM Macdonald, QJM 2001 94 53 56 11181980 10.1093/qjmed/94.2.53
14. 45calcium uptake in bone of rats. CD Seaborn FH Nielsen, J Trace Elem Exp Med 1994 7 11 18
15. Dietary silicon and arginine affect mineral element composition of rat femur and vertebra. CD Seaborn FH Nielsen, Biol Trace Elem Res 2002 89 239 250 12462747 10.1385/BTER:89:3:239
16. Growth-promoting effects of silicon in rats. K Schwarz DB Milne, Nature 1972 239 333 334 12635226 10.1038/239333a0
17. Silicon: a possible factor in bone calcification. EM Carlisle, Science 1970 167 279 280 5410261 10.1126/science.167.3916.279
18. In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. EM Carlisle, J Nutr 1976 106 4 478 484 1255267
19. Zeolite A increases proliferation, differentiation, and transforming growth factor production in normal adult human osteoblast-like cells in vitro. PE Keeting MJ Oursler KE Wiegand SK Bonde TC Spelsberg BL Riggs, J Bone Miner Res 1992 7 11 1281 1289 1334616
20. Zeolite A inhibits osteoclast-mediated bone resorption in vitro. N Schütze MJ Oursler J Nolan BL Riggs TC Spelsberg, J Cell Biochem 1995 58 39 46 7642721 10.1002/jcb.240580106
21. Silicon deficiency may be involved in bone disease of parenteral nutrition. AA Moukarzel M Song AL Buchman ME Ament, J Am Coll Nutr 1992 11 584
22. Silicium, tissu osseux et immunité A Schiano F Eisinger P Detolle AM Laponche B Brisou J Eisinger, Revue du Rhumatisme 1979 46 483 486
23. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. J Eisinger D Clairet, Magnes Res 1993 6 3 247 249 8292498
24. Dietary silicon intake is positively associated with bone mineral density in men and pre-menopausal women of the Framingham offspring cohort. R Jugdaohsingh KL Tucker N Qiao LA Cupples DP Kiel JJ Powell, J Bone Miner Res 2004 19 297 307 14969400 10.1359/JBMR.0301225
25. Dietary silicon intake is associated with bone mineral density in premenopausal women and postmenopausal women taking HRT. HM Macdonald AE Hardcastle R Jugdaohsingh DM Reid JJ Powell, J Bone Miner Res 2005 Suppl 20 S393
26. Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminium excretion. DM Reffitt R Jugdaohsingh RP Thompson JJ Powell, J Inorg Biochem 1999 76 141 147 10612067 10.1016/S0162-0134(99)00126-9
27. Orthosilicic acid stimulates collagen type I synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. DM Reffitt N Ogston R Jugdaohsingh HF Cheung BA Evans RP Thompson JJ Powell GN Hampson, Bone 2003 32 127 135 12633784 10.1016/S8756-3282(02)00950-X
28. Supplementation of calves with stabilized orthosilicic acid. Effect on the Si, Ca, Mg, and P concentrations in serum and the collagen concentration in skin and cartilage. MR Calomme DA Vanden Berghe, Biol Trace Elem Res 1997 56 153 165 9164661 10.1007/BF02785389
29. Effect of choline stabilized orthosilicic acid on bone density in chicks. MR Calomme P Wijnen JB Sindambiwe P Cos J Mertens P Geusens DA Vanden Berghe, Calcif Tissue Int 2002 70 292
30. Effect of oral intake of choline stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. A Barel M Calomme A Timchenko K De Paepe N Demeester V Rogiers P Clarys D Vanden Berghe, Arch Dermatol Res 2005 297 147 153 16205932 10.1007/s00403-005-0584-6
31. Partial prevention of long-term femoral bone loss in aged ovariectomized rats supplemented with choline-stabilized orthosilicic acid. M Calomme P Geusens N Demeester GJ Behets P D'Haese JB Sindambiwe V Van Hoof D Vanden Berghe, Calcif Tissue Int 2006 78 227 232 16604283 10.1007/s00223-005-0288-0
32. Dietary silicon intake in post-menopausal women. SA McNaughton C Bolton-Smith GD Mishra R Jugdaohsingh JJ Powell, Br J Nutr 2005 94 813 817 16277786 10.1079/BJN20051548
33. Management of osteoporosis. ME Lewiecki, Clin Mol Allergy 2004 2 9 15253771 10.1186/1476-7961-2-9
34. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trials. DC Bauer DM Black P Garnero M Hochberg S Ott J Orloff DE Thompson SK Ewing PD Delmas Fraction Intervention Trial Study Group, J Bone Miner Res 2004 19 1250 1258 15231011 10.1359/JBMR.040512
35. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. L Rejnmark NH Buus P Vestergaard L Heickendorff F Andreasen ML Larsen L Mosekilde, J Bone Miner Res 2004 19 737 744 15068496 10.1359/JBMR.040209
36. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover. LB Tanko YZ Bagger P Alexandersen JP Devogelaer JY Reginster R Chick M Olson H Benmammar L Mindeholm M Azria C Christiansen, J Bone Miner Res 2004 19 1531 1538 15312255 10.1359/JBMR.040715
37. Effects of silica on the bioactivity of calcium phosphate composites in vitro. CQ Ning J Mehta A El-Ghannam, J Mater Sci Mater Med 2005 16 355 360 15803281 10.1007/s10856-005-0635-8
38. A new way of incorporating silicon in hydroxyapatite (Si-Ha) as thin films. ES Thian J Huang SM Best ZH Barber W Bonfield, J Mater Sci Mater Med 2005 16 411 415 15875250 10.1007/s10856-005-6980-9
39. Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. S Ni J Chang L Chou W Zhai, J Biomed Mater Res B Appl Biomater 2007 80 174 183 16767735
40. Evaluation of the osteoblast response to a silica gel in vitro. SI Anderson S Downes CC Perry AM Caballero, J Mater Sci Mater Med 1998 9 731 735 15348931 10.1023/A:1008955002955
41. Bioactive glasses for in situ tissue regeneration. LL Hench ID Xynos JM Polak, J Biomater Sci Polym Ed 2004 15 543 562 15212333 10.1163/ 156856204323005352
42. Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. C Loty JM Sautier MT Tan M Oboeuf E Jallot H Boulekbache D Greenspan N Forest, J Bone Miner Res 2001 16 231 239 11204423 10.1359/jbmr.2001.16.2.231
43. Post translational modifications in the collagen of human osteoporotic femoral head. AJ Bailey SF Wotton TJ Sims PW Thompson, Biochem Biophys Res Comm 1992 185 801 805 1627138 10.1016/0006-291X(92)91697-O
44. Collagen and bone strength. AL Boskey TM Wright RD Blank, J Bone Miner Res 1999 14 330 335 10027897 10.1359/jbmr.1999.14.3.330
45. The role of collagen in bone strength. S Viguet-Carrin P Garnero PD Delmas, Osteoporosis Int 2006 17 319 336 10.1007/s00198-005-2035-9
46. Age-related changes in the collagen network and toughness of bone. X Wang X Shen X Li CM Agrawal, Bone 2002 31 1 7 12110404 10.1016/S8756-3282(01)00697-4
47. A bound form of silicon in glycosaminoglycans and polyuronides. K Schwarz, Proc Natl Acad Sci USA 1973 70 1608 1612 4268099 10.1073/pnas.70.5.1608
48. Silicon in food and diets. JAT Pennington, Food additives and contaminants 1991 8 97 118
49. Bioavailability of silicon from food and food supplements. K Van Dyck R Van Cauwenbergh H Robberecht H Deelstra, Fresenius J Anal Chem 1999 363 541 544 10.1007/s002160051243
50. Silicon absorption from stabilized orthosilicic acid and other supplements in healthy subjects. M Calomme P Cos P D'Haese R Vingerhoets L Lamberts M De Broe C Van Hoorebeke D Vanden Berghe, Trace Elem in Man and Animals Kluwer Academic/Plenum Publishers, Roussel et al, 2000 10 1111 1114
51. Diet and heart disease. The role of fat, alcohol, and antioxidants. JM Gaziano JE Manson, Cardiol Clin 1996 14 69 83 9072292
52. Magnesium and muscle performance in older persons: the InCHIANTI study. LJ Dominiguez M Barbagallo F Lauretani S Bandinelli A Bos AM Corsi EM Simonsick L Ferrucci, Am J Clin Nutr 2006 84 2 419 426 16895893
53. Choline, a vital amine. JK Blusztajn, Science 1998 281 794 795 9714685 10.1126/science.281.5378.794
54. The effects of manganese, biotin, and choline on hexosamine and hydroxyproline content as related to leg weakness. RH Stock JD Latshaw, Poult Sci 1981 60 5 1012 1016 7267542
55. Mandibular bone remodeling under a choline-deficient diet: a histomorphometric study in rats. AA Gorustovich MA Esposito MB Guglielmotti MJ Giglio, J Periodontol 2003 74 831 837 12886993 10.1902/jop.2003.74.6.831